BDBM31536 pyrazolo[4,3-h]quinazoline-3-carboxamide, 19

SMILES: Cn1nc(C(=O)NC2CCCC2)c2CCc3cnc(Nc4ccccc4)nc3-c12

InChI Key: InChIKey=JBZSHFMYVGCDBI-UHFFFAOYSA-N

Data: 5 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 31536   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cyclin-Dependent Kinase 2 (CDK2) (Homo sapiens (Human))	BDBM31536 (pyrazolo[4,3-h]quinazoline-3-carboxamide, 19) Show SMILES Cn1nc(C(=O)NC2CCCC2)c2CCc3cnc(Nc4ccccc4)nc3-c12 Show InChI InChI=1S/C22H24N6O/c1-28-20-17(19(27-28)21(29)24-15-9-5-6-10-15)12-11-14-13-23-22(26-18(14)20)25-16-7-3-2-4-8-16/h2-4,7-8,13,15H,5-6,9-12H2,1H3,(H,24,29)(H,23,25,26)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	3.90E+3	n/a	n/a	n/a	n/a	7.4	23
Nerviano Medical Sciences Srl					Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates, followed by quantitation of the phosphorylat...				J Med Chem 52: 5152-63 (2009) Article DOI: 10.1021/jm9006559 BindingDB Entry DOI: 10.7270/Q2JH3JJP
					More data for this Ligand-Target Pair
Aurora kinase A (Homo sapiens (Human))	BDBM31536 (pyrazolo[4,3-h]quinazoline-3-carboxamide, 19) Show SMILES Cn1nc(C(=O)NC2CCCC2)c2CCc3cnc(Nc4ccccc4)nc3-c12 Show InChI InChI=1S/C22H24N6O/c1-28-20-17(19(27-28)21(29)24-15-9-5-6-10-15)12-11-14-13-23-22(26-18(14)20)25-16-7-3-2-4-8-16/h2-4,7-8,13,15H,5-6,9-12H2,1H3,(H,24,29)(H,23,25,26)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	25
Nerviano Medical Sciences Srl					Assay Description The biochemical activity of compounds was determined by incubation with specific enzymes and substrates, followed by quantitation of the phosphorylat...				J Med Chem 52: 5152-63 (2009) Article DOI: 10.1021/jm9006559 BindingDB Entry DOI: 10.7270/Q2JH3JJP
					More data for this Ligand-Target Pair
Aurora kinase A (Homo sapiens (Human))	BDBM31536 (pyrazolo[4,3-h]quinazoline-3-carboxamide, 19) Show SMILES Cn1nc(C(=O)NC2CCCC2)c2CCc3cnc(Nc4ccccc4)nc3-c12 Show InChI InChI=1S/C22H24N6O/c1-28-20-17(19(27-28)21(29)24-15-9-5-6-10-15)12-11-14-13-23-22(26-18(14)20)25-16-7-3-2-4-8-16/h2-4,7-8,13,15H,5-6,9-12H2,1H3,(H,24,29)(H,23,25,26)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Nerviano Medical Sciences Srl Curated by ChEMBL					Assay Description Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting				J Med Chem 53: 3532-51 (2010) Article DOI: 10.1021/jm901713n BindingDB Entry DOI: 10.7270/Q2RF5V5D
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase PLK1 (Homo sapiens (Human))	BDBM31536 (pyrazolo[4,3-h]quinazoline-3-carboxamide, 19) Show SMILES Cn1nc(C(=O)NC2CCCC2)c2CCc3cnc(Nc4ccccc4)nc3-c12 Show InChI InChI=1S/C22H24N6O/c1-28-20-17(19(27-28)21(29)24-15-9-5-6-10-15)12-11-14-13-23-22(26-18(14)20)25-16-7-3-2-4-8-16/h2-4,7-8,13,15H,5-6,9-12H2,1H3,(H,24,29)(H,23,25,26)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Nerviano Medical Sciences Srl Curated by ChEMBL					Assay Description Inhibition of GST-tagged PLK1 expressed in H5 insect cells assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting				J Med Chem 53: 3532-51 (2010) Article DOI: 10.1021/jm901713n BindingDB Entry DOI: 10.7270/Q2RF5V5D
					More data for this Ligand-Target Pair
CDK2/Cyclin A/Cyclin A1 (Homo sapiens (Human))	BDBM31536 (pyrazolo[4,3-h]quinazoline-3-carboxamide, 19) Show SMILES Cn1nc(C(=O)NC2CCCC2)c2CCc3cnc(Nc4ccccc4)nc3-c12 Show InChI InChI=1S/C22H24N6O/c1-28-20-17(19(27-28)21(29)24-15-9-5-6-10-15)12-11-14-13-23-22(26-18(14)20)25-16-7-3-2-4-8-16/h2-4,7-8,13,15H,5-6,9-12H2,1H3,(H,24,29)(H,23,25,26)	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	3.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
Nerviano Medical Sciences Srl Curated by ChEMBL					Assay Description Inhibition of CDK2/Cyclin A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting				J Med Chem 53: 3532-51 (2010) Article DOI: 10.1021/jm901713n BindingDB Entry DOI: 10.7270/Q2RF5V5D
					More data for this Ligand-Target Pair